To include your compound in the COVID-19 Resource Center, submit it here.

BMS-955176: Phase IIa data

The double-blind, dose-escalation, international Phase IIa AI468002 trial in 60 patients with HIV-1 infection showed that once-daily

Read the full 170 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE